Clinical Analysis of Methylprednisolone in Treatment of Refractory Mycoplasma Pneumoniae Pneumonia in Children
WANG Xiao-dong
Abstract：Objective To explore the application value of methylprednisolone in the treatment of refractory Mycoplasma pneumonia in children.Methods 85 children with refractory Mycoplasma pneumoniae pneumonia from April, 2014 to January, 2018, wereselected as subjects. The control group were treated with routine treatment such as azithromycin antimycoplasma, and the study groupwere treated with methylprednisolone. The fever time, cough relief time, CRP improvement and total effective rate were compared be-tween the two groups.Results Fever time and cough relief time in control group were significantly higher than the study group, andthe difference was significant (P＜0.05). The CRP level of the two groups after treatment was significantly lower than that before treat-ment, and the study group was significantly lower than that of the control group (P＜0.05). The total effective rate of the control groupwas 78.57％, which was significantly lower than 95.35％ of the study group. There was statistically significant difference (P＜0.05). Conclusion The combination of methylprednisolone in the treatment of refractory Mycoplasma pneumoniae pneumonia in children canshorten the course of disease, improve symptoms quickly, have outstanding anti-inflammatory effect, and improve the total effective rate of treatment.
Keywords：Mycoplasma pneumoniae pneumoniaIntractableMethylprednisolone
Publication Date：2019-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 60-61,64 )